FUCIDIN H 1 %
HYDROCORTISONE ACETATE : 1 % FUSIDIC ACID : 2 % · DIN 02238578 · LEO PHARMA INC
Health Canada status: MARKETED
What is FUCIDIN H?
FUCIDIN H 1 % contains HYDROCORTISONE ACETATE : 1 % FUSIDIC ACID : 2 %. It is listed in the Health Canada Drug Product Database under DIN 02238578, held by LEO PHARMA INC, supplied as CREAM for TOPICAL administration. Health Canada currently lists it as marketed, status dated 11-Nov-1998. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is FUCIDIN H used for?
Treatment of mild to moderately severe atopic dermatitis where Staphylococcus aureus is suspected as a contributing factor. Has antibacterial and anti-inflammatory activity.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02238578 |
|---|---|
| Brand name | FUCIDIN H |
| Generic / active ingredient | HYDROCORTISONE ACETATE : 1 % FUSIDIC ACID : 2 % |
| Manufacturer | LEO PHARMA INC |
| Strength | 1 % |
| Dosage form | CREAM |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | D07CA01 HYDROCORTISONE AND ANTIBIOTICS |
| AHFS class | 84:06.00 ; 84:04.04 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 11-Nov-1998 |
| Original market date | 1998-11-11 00:00:00 |
How is it administered?
Apply 3 times daily and gently massage into affected areas. Treatment period in clinical trials was 14 days; consider shorter course if symptoms improve.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store below 30 °C. Use within 3 months of first opening the tube.
How is it supplied?
30 g aluminium tubes covered with internal epoxyphenol lacquer, with re-closable high density polyethylene screw cap.
Contraindications
Hypersensitivity to ingredients; primary skin infections (fungal, viral, bacterial) untreated/uncontrolled; tuberculosis skin manifestations; vaccination eruptions; perioral dermatitis; rosacea.
Warnings and precautions
Avoid long-term use (>14 days). Risk of HPA axis suppression, Cushing’s syndrome, and antibiotic resistance. Avoid contact with eyes (risk of glaucoma/cataracts).
What can be used instead?
Other Canadian products sharing ATC code D07CA01 HYDROCORTISONE AND ANTIBIOTICS. 2 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| VIOFORM HYDROCORTISONE | 3 % | CREAM | ENDO OPERATIONS LTD. | MARKETED | DIN 00074500 |
| CORTISPORIN | 5 MG | OINTMENT | GLAXOSMITHKLINE INC | CANCELLED POST MARKET | DIN 00666246 |
| NEO-CORTEF 0.5% OINTMENT | 0.5 % | OINTMENT | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 00194891 |
| NEO-CORTEF 1% OINTMENT | 0.5 % | OINTMENT | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 00194913 |
| VIOFORM + HYDROCORTISONE | 1 % | OINTMENT | CIBA PHARMACEUTICALS, CIBA-GEIGY CANADA LTD. | CANCELLED POST MARKET | DIN 00074527 |
| VIOFORM HYDROCORTISONE MILD | 3 % | CREAM | NOVARTIS PHARMACEUTICALS CANADA INC | CANCELLED POST MARKET | DIN 00074489 |
Who else supplies HYDROCORTISONE AND ANTIBIOTICS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. HYDROCORTISONE AND ANTIBIOTICS appears in 37 registered pack listings across 7 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.